ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2

Traeger L, Gallitz I, Sekhri R, Baeumer N, Kuhlmann T, Kemming C, Holtkamp M, Mueller J, Karst U, Canonne-Hergaux F, Muckenthaler MU, Bloch DB, Olschewski A, Bartnikas TB, Steinbicker AU (2018)

In: Free Radical Biology and Medicine, 129.

Research article (journal)

Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy.

Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016)

In: Cancer Research, 76(24).

Research article (journal)

Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1

Bäumer N., Bäumer S., Berkenfeld F., Stehling M., Köhler G., Berdel W., Müller-Tidow C., Tschanter P. (2014)

In: PloS one, 9(12).

Research article (journal)

Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival

Tickenbrock L, Klein HU, Trento C, Hascher A, Göllner S, Bäumer N, Kuss R, Agrawal S, Bug G, Serve H, Thiede C, Ehninger G, Stadt UZ, McClelland M, Wang Y, Becker A, Koschmieder S, Berdel WE, Dugas M, Müller-Tidow C, for the SAL (Study Alliance Leukemia) Group (2011)

In: Leukemia Research, 35(5).

Research article (journal)

Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling.

Bäumer N, Tickenbrock L, Tschanter P, Lohmeyer L, Diederichs S, Bäumer S, Skryabin BV, Zhang F, Agrawal-Singh S, Köhler G, Berdel WE, Serve H, Koschmieder S, Müller-Tidow C (2011)

In: Journal of Biological Chemistry, 286(32).

Research article (journal)

Publications

Operated by

Top-Links

Tumor-Cell-Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody-Inhibitor Conjugates (AiCs) Faust A, Bäumer N, Schlütermann A, Becht M, Greune L, Geyer C, Rüter C, Margeta R, Wittmann L, Dersch P, Lenz G, Berdel WE, Bäumer S. (2022) In: Angewandte Chemie International Edition, 61(1), e202109769. Research article (journal)
ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2 Traeger L, Gallitz I, Sekhri R, Baeumer N, Kuhlmann T, Kemming C, Holtkamp M, Mueller J, Karst U, Canonne-Hergaux F, Muckenthaler MU, Bloch DB, Olschewski A, Bartnikas TB, Steinbicker AU (2018) In: Free Radical Biology and Medicine, 129. Research article (journal)
Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation Lofruthe N, Gallitz I, Traeger L, Baeumer N, Schulze I, Kuhlmann T, Mueller-Tidow C, Steinbicker AU (2016) In: PloS one, 11(7). Research article (journal)
Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy. Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016) In: Cancer Research, 76(24). Research article (journal)
Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer Bäumer S., Bäumer N., Appel N., Terheyden L., Fremerey J., Schelhaas S., Wardelmann E., Buchholz F., Berdel W., Müller-Tidow C. (2015) In: Clinical Cancer Research, 21(6). Research article (journal)
Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1 Bäumer N., Bäumer S., Berkenfeld F., Stehling M., Köhler G., Berdel W., Müller-Tidow C., Tschanter P. (2014) In: PloS one, 9(12). Research article (journal)
Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functions. Bäumer N, Krause A, Köhler G, Lettermann S, Evers G, Hascher A, Bäumer S, Berdel WE, Müller-Tidow C, Tickenbrock L (2014) In: PloS one, 9(4). Research article (journal)
Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival Tickenbrock L, Klein HU, Trento C, Hascher A, Göllner S, Bäumer N, Kuss R, Agrawal S, Bug G, Serve H, Thiede C, Ehninger G, Stadt UZ, McClelland M, Wang Y, Becker A, Koschmieder S, Berdel WE, Dugas M, Müller-Tidow C, for the SAL (Study Alliance Leukemia) Group (2011) In: Leukemia Research, 35(5). Research article (journal)
The inhibitor of growth protein 5 (ING5) depends on INCA1 as a co-factor for its antiproliferative effects. Zhang F, Bäumer N, Rode M, Ji P, Zhang T, Berdel WE, Müller-Tidow C (2011) In: Head and Face Medicine, 6(7). Research article (journal)
Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling. Bäumer N, Tickenbrock L, Tschanter P, Lohmeyer L, Diederichs S, Bäumer S, Skryabin BV, Zhang F, Agrawal-Singh S, Köhler G, Berdel WE, Serve H, Koschmieder S, Müller-Tidow C (2011) In: Journal of Biological Chemistry, 286(32). Research article (journal)